نتائج البحث - "Monika G. Looijen‐Salamon"

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Groningen Research Institute for Asthma and COPD (GRIAC), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Targeted Gynaecologic Oncology (TARGON), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Pulmonologie, MUMC+: MA Med Staf Spec Longziekten (9), Pathologie, RS: GROW - R2 - Basic and Translational Cancer Biology, UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - SSS/IREC/MORF - Pôle de Morphologie, UCL - (MGD) Service d'anatomie pathologique, UCL - (MGD) Service de pneumologie, Pathology, Epidemiology and Data Science, APH - Methodology, CCA - Cancer Treatment and quality of life, Pulmonary medicine

المصدر: Lung cancer: journal of the International Association for the Study of Lung Cancer
Lung Cancer, 138, pp. 13-18
Lung Cancer, 138, 13-18
Lung Cancer
Lung Cancer, 138, 13-18. ELSEVIER IRELAND LTD
Thunnissen, E, Lissenberg-Witte, B I, van den Heuvel, M M, Monkhorst, K, Skov, B G, Sørensen, J B, Mellemgaard, A, Dingemans, A M C, Speel, E J M, de Langen, A J, Hashemi, S M S, Bahce, I, van der Drift, M A, Looijen-Salamon, M G, Gosney, J, Postmus, P E, Samii, S M S, Duplaquet, F, Weynand, B, Durando, X, Penault-Llorca, F, Finn, S, Grady, A O, Oz, B, Akyurek, N, Buettner, R, Wolf, J, Bubendorf, L, Duin, S, Marondel, I, Heukamp, L C, Timens, W, Schuuring, E M D, Pauwels, P & Smit, E F 2019, ' ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib ', Lung Cancer, vol. 138, pp. 13-18 . https://doi.org/10.1016/j.lungcan.2019.09.023Test
Lung Cancer, 138, 13-18. Elsevier Ireland Ltd
Lung cancer, Vol. 138, p. 13-18 (2019)

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Lung Neoplasms, INTERNATIONAL-ASSOCIATION, Stress-related disorders Donders Center for Medical Neuroscience [Radboudumc 13], 0302 clinical medicine, alk, Non-small cell lung cancer, Carcinoma, Non-Small-Cell Lung, hemic and lymphatic diseases, Anaplastic lymphoma kinase, Anaplastic Lymphoma Kinase, Prospective Studies, In Situ Hybridization, Fluorescence, Gene Rearrangement, fluorescence in situ hybridisation, medicine.diagnostic_test, treatment, REARRANGEMENT, Middle Aged, OF-AMERICAN-PATHOLOGISTS, Prognosis, Disorders of movement Donders Center for Medical Neuroscience [Radboudumc 3], Immunohistochemistry, PREVALENCE, Survival Rate, LUNG-CANCER PATIENTS, Treatment Outcome, 030220 oncology & carcinogenesis, immunohistochemistry, Fish , Female, Non small cell, medicine.drug, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Rare cancers Radboud Institute for Molecular Life Sciences [Radboudumc 9], 03 medical and health sciences, MOLECULAR TESTING GUIDELINE, All institutes and research themes of the Radboud University Medical Center, Crizotinib, Internal medicine, Biopsy, medicine, Humans, Protein Kinase Inhibitors, non-small cell lung cancer, business.industry, ADENOCARCINOMA, Treatment, 030104 developmental biology, COPY NUMBER, ALK, KINASE INHIBITORS GUIDELINE, Fluorescence in situ hybridisation, Human medicine, prognosis, business, Stage iv, Fluorescence in situ hybridization, IHC

وصف الملف: pdf; application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fbd4c2857be1034f64d88d9f7a78b17Test
https://doi.org/10.1016/j.lungcan.2019.09.023Test

4

Glucose and glutamine metabolism in relation to mutational status in NSCLC histological subtypes

المؤلفون: Michel M van den Heuvel, Johan Bussink, Paul N. Span, Monika G. Looijen-Salamon, Johannes H.A.M. Kaanders, Jasper Lok, Tineke W.H. Meijer, Bastiaan B J Tops

المصدر: Thoracic Cancer, Vol 10, Iss 12, Pp 2289-2299 (2019)
Thoracic Cancer, 10, 2289-2299
Thoracic Cancer, 10, 12, pp. 2289-2299
Thoracic Cancer

مصطلحات موضوعية: non‐small cell lung cancer, 0301 basic medicine, Pulmonary and Respiratory Medicine, Lung Neoplasms, Glutamine, Cell, Fluorescent Antibody Technique, Rare cancers Radboud Institute for Molecular Life Sciences [Radboudumc 9], medicine.disease_cause, mutational status, lcsh:RC254-282, 03 medical and health sciences, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Biomarkers, Tumor, medicine, Humans, Genetic Predisposition to Disease, Genetic Association Studies, Neoplasm Staging, Messenger RNA, Women's cancers Radboud Institute for Molecular Life Sciences [Radboudumc 17], biology, business.industry, Glucose transporter, Original Articles, General Medicine, glycolysis, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Glucose, 030104 developmental biology, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, Mutation, biology.protein, Cancer research, Glutamine metabolism, Adenocarcinoma, Original Article, GLUT1, KRAS, business, Glucose Transporter Type 1, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9]

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::405265537daea13a05ce68564bf55954Test
https://doi.org/10.1111/1759-7714.13226Test

5

Neural image compression for non-small cell lung cancer subtype classification in H&E stained whole-slide images

المؤلفون: Monika G. Looijen-Salamon, Gabriel Raya, Lieke L. van der Woude, Francesco Ciompi, Jeroen van der Laak, Witali Aswolinskiy, David Tellez, Katrien Grünberg

المصدر: Medical Imaging 2021: Digital Pathology.

مصطلحات موضوعية: Computer science, business.industry, Deep learning, Cancer, Pattern recognition, medicine.disease, Convolutional neural network, medicine, Adenocarcinoma, Non small cell, Artificial intelligence, Lung cancer, Subtype classification, business, Image compression

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::c0dde7a138533dd67a80f69771bfe5b8Test
https://doi.org/10.1117/12.2581943Test

6

Clinical outcomes and molecular profiling of advanced metastatic castration-resistant prostate cancer patients treated with (225)Ac-PSMA-617 targeted alpha-radiation therapy

المؤلفون: Winald R. Gerritsen, Monika G. Looijen-Salamon, Inge M. van Oort, Leonie I. Kroeze, Uwe Haberkorn, Frank Bruchertseifer, Clemens Kratochwil, José A. E. Custers, Niven Mehra, Peter H.J. Slootbeek, Maarten J. van der Doelen, Alfred Morgenstern, Marcel J.R. Janssen, James Nagarajah

المصدر: Urologic Oncology-Seminars and Original Investigations, 39, 10, pp. 729.e7-729.e16
Urologic Oncology-Seminars and Original Investigations, 39, 729.e7-729.e16

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Urology, Cancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2], 030232 urology & nephrology, Castration resistant, Rare cancers Radboud Institute for Molecular Life Sciences [Radboudumc 9], urologic and male genital diseases, 03 medical and health sciences, Prostate cancer, 0302 clinical medicine, Antigen, Internal medicine, Urological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15], medicine, Clinical endpoint, Glutamate carboxypeptidase II, Tumours of the digestive tract Radboud Institute for Molecular Life Sciences [Radboudumc 14], business.industry, medicine.disease, ddc, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], 030220 oncology & carcinogenesis, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], Cohort, Immunohistochemistry, business, Cohort study

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9eacf94286e8dbf9d81c066c59b25afTest
https://doi.org/10.1016/j.urolonc.2020.12.002Test

7

Clinical outcomes and molecular profiling of advanced metastatic castration-resistant prostate cancer patients treated with

المؤلفون: Maarten J, van der Doelen, Niven, Mehra, Inge M, van Oort, Monika G, Looijen-Salamon, Marcel J R, Janssen, José A E, Custers, Peter H J, Slootbeek, Leonie I, Kroeze, Frank, Bruchertseifer, Alfred, Morgenstern, Uwe, Haberkorn, Clemens, Kratochwil, James, Nagarajah, Winald R, Gerritsen

المصدر: Urologic oncology. 39(10)

مصطلحات موضوعية: Actinium, Male, Prostatic Neoplasms, Castration-Resistant, Treatment Outcome, Humans, Neoplasm Metastasis, Prostate-Specific Antigen

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid________::28d3015e74a1a3024c074f3fc5ac979cTest
https://pubmed.ncbi.nlm.nih.gov/33353867Test

8

A deep learning approach to assess the predominant tumor growth pattern in whole-slide images of lung adenocarcinoma

المؤلفون: Arkadiusz Gertych, Francesco Ciompi, Lieke L. van der Woude, Zaneta Swiderska-Chadaj, Karolina Nurzynska, Bartłomiej Grala, Tomasz Markiewicz, Katrien Grünberg, Monika G. Looijen-Salamon, Ann E. Walts

المصدر: Medical Imaging: Digital Pathology

مصطلحات موضوعية: Pathology, medicine.medical_specialty, Lung, business.industry, Concordance, Kappa score, Digital pathology, medicine.disease, medicine.anatomical_structure, medicine, Cribriform, Adenocarcinoma, Tumor growth, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::3393322742c0a2431449a2adbacf7d7fTest
https://doi.org/10.1117/12.2549742Test

9

Plasma Cells and Endothelitis in COVID-19 Lung Pathology

المؤلفون: Quirijn van der Mast, Sanne Vermorgen, Johannes G. van der Hoeven, Monika G. Looijen-Salamon, Frank L. van de Veerdonk, Sarah van Belle, Michel M van den Heuvel, Catrien van der Meer, Mihai G. Netea, Katrien Grünberg, Shoko Vos

المصدر: SSRN Electronic Journal.

مصطلحات موضوعية: Anakinra, medicine.medical_specialty, Pathology, Lung, business.industry, Lung biopsy, Plasma cell, Epithelial Damage, medicine.anatomical_structure, Metaplasia, medicine, Histopathology, medicine.symptom, business, Diffuse alveolar damage, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::7034517fff6b51ccbfd9418a6fd4bcf5Test
https://doi.org/10.2139/ssrn.3596608Test

10

Dichotomous ALK-IHC Is a Better Predictor for ALK Inhibition Outcome than Traditional ALK-FISH in Advanced Non–Small Cell Lung Cancer

المؤلفون: Ernst-Jan M. Speel, Nils A. 't Hart, B. E. van den Borne, E. Van Der Heijden, Monika G. Looijen-Salamon, S. Riemersma, Lizza E.L. Hendriks, A. J. van der Wekken, Harry J.M. Groen, Ed Schuuring, Wim Timens, R. Pelgrim, A. Van Den Berg, Thijo J N Hiltermann, A.J. de Langen, N Werner, J. Staal-van den Brekel, Anne-Marie C. Dingemans, M. F. Mastik

المساهمون: Stem Cell Aging Leukemia and Lymphoma (SALL), Translational Immunology Groningen (TRIGR), Groningen Research Institute for Asthma and COPD (GRIAC), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Targeted Gynaecologic Oncology (TARGON), Guided Treatment in Optimal Selected Cancer Patients (GUTS), CCA - Cancer Treatment and quality of life, Pulmonary medicine, Pulmonologie, Promovendi ODB, MUMC+: MA Med Staf Spec Longziekten (9), RS: GROW - R2 - Basic and Translational Cancer Biology, Pathologie, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Epidemiologie

المصدر: Clinical Cancer Research, 23(15), 4251-4258. AMER ASSOC CANCER RESEARCH
Europe PubMed Central
Clinical Cancer Research, 23(15), 4251-4258. American Association for Cancer Research Inc.
Clinical Cancer Research, 23, 4251-4258
Clinical Cancer Research, 23, 15, pp. 4251-4258
Van Der Wekken, A J, Pelgrim, R, T Hart, N, Werner, N, Mastik, M F, Hendriks, L, Van Der Heijden, E H F M, Looijen-Salamon, M, De Langen, A J, Staal-Van Den Brekel, J, Riemersma, S, Van Den Borne, B E, Speel, E J M, Dingemans, A M C, Hiltermann, T J N, Van Den Berg, A, Timens, W, Schuuring, E & Groen, H J M 2017, ' Dichotomous ALK-IHC is a better predictor for ALK inhibition outcome than traditional ALK-FISH in advanced non–small cell lung cancer ', Clinical Cancer Research, vol. 23, no. 15, pp. 4251-4258 . https://doi.org/10.1158/1078-0432.CCR-16-1631Test

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Pathology, Pyridines, FUSION, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, hemic and lymphatic diseases, Anaplastic lymphoma kinase, Anaplastic Lymphoma Kinase, GENE REARRANGEMENT, In Situ Hybridization, Fluorescence, CRIZOTINIB THERAPY, medicine.diagnostic_test, Middle Aged, Prognosis, Gene Expression Regulation, Neoplastic, CARCINOMAS, 030220 oncology & carcinogenesis, Adenocarcinoma, Female, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], medicine.drug, Adult, medicine.medical_specialty, Biopsy, Fine-Needle, Rare cancers Radboud Institute for Molecular Life Sciences [Radboudumc 9], Disease-Free Survival, 03 medical and health sciences, Crizotinib, Internal medicine, Biopsy, Biomarkers, Tumor, medicine, Carcinoma, Humans, IMMUNOHISTOCHEMISTRY, Lung cancer, Aged, IDENTIFICATION, business.industry, Receptor Protein-Tyrosine Kinases, Cancer, ADENOCARCINOMA, Gene rearrangement, IN-SITU HYBRIDIZATION, medicine.disease, COPY NUMBER, 030104 developmental biology, Pyrazoles, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::294301d2488887f96efb73185cf8e257Test
https://doi.org/10.1158/1078-0432.ccr-16-1631Test

تنقيح النتائج